With rezpegaldesleukin (rezpeg) phase IIb data in alopecia areata holding strong over time, backers of Nektar Therapeutics Inc. are hopeful that the biologic can do for the hair loss market what ...

When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on machine learning has identified ...

Biogen Inc. has consolidated full global rights to felzartamab through an $850 million deal with TJ Biopharma Co. Ltd. April ...

Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a surge in investment in companies ...

A modified version of CRISPR-Cas9 has enabled, for the first time, the efficient integration of a large transgene capable of ...

*For more details about COVID-19 therapeutics and vaccines, diagnostic products and clinical trial delays, go to BioWorld Snapshots.

Actionable intelligence on advances in medical devices and technologies for 20+ years ...

Kailera Therapeutics Inc.’s “obesity-first” approach continues to resonate with investors, with the company pricing an ...

Researchers from the Government College University Faisalabad reported the discovery and preclinical characterization of IMS-48, a benzimidazole analogue designed to inhibit both acetylcholinesterase ...

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Aligos, Amgen, Amoytop, Astellas, Caredx, Cathether, Daiichi, Eurobio, Interna, Johnson & Johnson, Mabwell ...

Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as... Copyright ©2026. All Rights Reserved.

Cisplatin is widely used in chemotherapy regimens for many solid tumors, yet its therapeutic benefit is counterbalanced by significant toxicity and immunologically related limitations. Researchers ...